Stockscreener 앱 받기
1.12
7.44%
-0.09
전일 마감가:
$1.21
열려 있는:
$1.21
하루 거래량:
18,855
Relative Volume:
0.42
시가총액:
$7.33M
수익:
$500.00K
순이익/손실:
$-9.78M
주가수익비율:
-0.7264
EPS:
-1.5419
순현금흐름:
$-8.10M
1주 성능:
+12.00%
1개월 성능:
-14.50%
6개월 성능:
-71.69%
1년 성능:
-78.00%
1일 변동 폭
$1.10
$1.24
1주일 범위
$0.936
$1.26
52주 변동 폭
$0.936
$9.4799
Exicure Inc Stock (XCUR) Company Profile
명칭
Exicure Inc
전화
847-673-1707
주소
2430 N. HALSTED ST., CHICAGO, IL
Compare XCUR vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XCUR
Exicure Inc
|
1.12 | 7.33M | 500.00K | -9.78M | -8.10M | -1.5419 |
VRTX
Vertex Pharmaceuticals Inc
|
508.74 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.35 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.50 | 53.23B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.30 | 42.34B | 5.76B | 514.49M | 1.10B | 4.4813 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-12-13 | 다운그레이드 | Chardan Capital Markets | Buy → Neutral |
| 2020-12-18 | 개시 | BMO Capital Markets | Outperform |
| 2019-11-20 | 개시 | Guggenheim | Buy |
Exicure Inc 주식(XCUR)의 최신 뉴스
Exicure Gets Nasdaq Extension as Delisting Risk Persists - MyChesCo
Cyngn Inc.Common stock (NQ: CYN - The Chronicle-Journal
Exicure Inc (NASDAQ: XCUR) Share Price, XCUR Stock News, XCUR Share Price & Updates - kalkine.ca
Nasdaq gives Exicure until Dec. 2 to show it has $2.5 million left after debts - Stock Titan
Free cash flow of Exicure, Inc. – HAM:2H0 - TradingView
Cash flow from investing activities of Exicure, Inc. – HAM:2H0 - TradingView
Total common shares outstanding of Exicure, Inc. – HAM:2H0 - TradingView
Return on assets % of Exicure, Inc. – HAM:2H0 - TradingView
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - Barchart.com
Exicure (XCUR) Watch: Falls 11.54% to $1.15 in the Latest Session; Range View: Support at $1.09 and Resistance at $1.21 Frame the RangeRounding Top - vinanet.vn
Exicure (XCUR) Price: Declines 11.54% to $1.15 in the Latest Reading; Range View: Support at $1.09 and Resistance at $1.21 Frame the Range for the Current SessionEqual Weight ETF - vinanet.vn
Exicure (XCUR) Quarterly Figures: EPS Comes in Below Forecast for This Review; Share Response: The Stock Ends Down 10.34% for the Current SessionGuidance Update - vinanet.vn
Exicure Stock Price Forecast. Should You Buy XCUR? - StockInvest.us
EXICURE, INC. Q2 2026: Revenue $0 Net income $(1.12M) — 10-Q Summary - TradingView
Exicure Deadline Alert - TMX Newsfile
Exicure Update - TMX Newsfile
Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Exicure Inc (XCUR) Stock News Today - TradingKey
XCUR Q2 2022 Earnings: Wider-than-Expected Loss Weighs on SharesCFO Commentary Report - vinanet.vn
Trading Systems Reacting to (XCUR) Volatility - Stock Traders Daily
Exicure Shareholder Alert - TMX Newsfile
XCUR Looks 231.6% Overvalued on GF Value™ - GuruFocus
Exicure to issue shares to settle $1M clinical milestone payment - Investing.com
Exicure to issue shares to settle $1M clinical milestone payment By Investing.com - Investing.com Nigeria
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - The Manila Times
Exicure Announces Planned Issuance of Common Stock to Settle $1.0 Million Milestone Payment to GPCR Therapeutics - Quiver Quantitative
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance - Yahoo Finance Singapore
XCUR Q2 2022 Earnings: EPS Misses by 35.6% as No Revenue ReportedDividend Cut Risk - vinanet.vn
Exicure Inc. (XCUR) Rises 4.46% to $1.64 as Shares Approach Key Resistance LevelETF Creation Redemption - vinanet.vn
Exicure Shareholder Alert - TMX Newsfile
Exicure Inc (XCUR) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Exicure Inc (XCUR) Cash Flow - TradingKey
Exicure Inc (XCUR) Institutional Confidence - TradingKey
Exicure Inc (XCUR) Balance Sheet - TradingKey
Exicure Inc (XCUR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Exicure Inc (XCUR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Exicure Inc (XCUR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
XCUR|Exicure Inc|Price:1.330|Chg%:-0.180 - TradingKey
XCUR|Exicure Inc|Price:1.750|Chg%:-0.010 - TradingKey
XCUR|Exicure Inc|Price:1.760|Chg%:+0.050 - TradingKey
XCUR Q2 2022 Earnings: EPS Misses Estimates Amid Development ChallengesGuidance Revision Trend - vinanet.vn
Exicure Inc (XCUR) Income Statement - TradingKey
Exicure, Inc. Revenue Breakdown – NASDAQ:XCUR - TradingView
Exicure Inc (XCUR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
XCUR stock trades on limited evidence as Exicure waits for filings - Ad-hoc-news.de
XCUR|Exicure Inc|Price:1.700|Chg%:-0.010 - TradingKey
XCUR Q2 2022 Earnings: EPS Misses Estimates, Stock Declines as Pre-Revenue Biotech Faces ChallengesOperating Margin Analysis - vinanet.vn
Form 4 Exicure Inc For: 17 July By Investing.com - Investing.com Nigeria
Exicure Inc. (XCUR) Q2 2022 Earnings: EPS Misses Estimates Significantly, Stock Rises 3.7%Earnings Decline Risk - vinanet.vn
Form 13D/A EXICURE For: 17 July By Investing.com - Investing.com Nigeria
Exicure Inc (XCUR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Exicure Inc 주식 (XCUR) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Exicure HiTron Inc. | 10% Owner |
Jan 16 '26 |
Sale |
4.50 |
734,747 |
3,306,362 |
1,857,314 |
| Exicure HiTron Inc. | 10% Owner |
Jan 07 '26 |
Sale |
4.50 |
741,272 |
3,335,724 |
2,592,061 |
| SANGSANGIN INVESTMENT & SECURI | 10% Owner |
Dec 08 '25 |
Sale |
8.71 |
433,332 |
3,774,322 |
0 |
1.49%
자본화:
|
볼륨(24시간):